Hypokalemia clinical trials
The registry lists 38 studies for Hypokalemia across more than 10 countries. 5 are recruiting or about to start. 14 of them are mainly about Hypokalemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-22.
Get an email when these change. Save the Hypokalemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Assistance Publique - Hôpitaux de Paris (4) · University of Oulu (2) · Larissa University Hospital (2) · Changi General Hospital (2) · Icahn School of Medicine at Mount Sinai (1) · Sohag University (1) · Centre Hospitalier Régional Metz-Thionville (1) · The Queen Elizabeth Hospital (1)
What is being tested here
Drugs under test in Hypokalemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
Who these studies take
Of the 3 Hypokalemia studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 1 (33%) |
| 18 | 2 (67%) | 2 (67%) |
| 30 | 2 (67%) | 2 (67%) |
| 40 | 2 (67%) | 2 (67%) |
| 50 | 2 (67%) | 2 (67%) |
| 65 | 2 (67%) | 2 (67%) |
| 75 | 1 (33%) | 1 (33%) |
| 85 | 1 (33%) | 1 (33%) |
Across all 38 studies, recruiting or not: 45% stop at 75 or younger and 24% at 65; 26% take children; 0% are for women only and 3% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 38 of 38. search them.
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT042784042 countries
- Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and HypertensionRecruitingNCT07470580Not applicable1 country
- Combination Osilodrostat and Cabergoline in Cushing's DiseaseEnrolling by invitationNCT07603466Phase 41 country
- Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to TreatRecruitingNCT065695891 country
- The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis PatientsNot yet recruitingNCT06736184Phase 4
- Management of Hypokalemia in Intensive Care PatientsCompletedNCT07833722Not applicable1 country
- Potassium Supplementation in CKDActive, not recruitingNCT03253172Not applicable1 country
- Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic ComplicationsCompletedNCT05443802Not applicable1 country
- Targeted Potassium Levels for Prevention of ICD TherapyActive, not recruitingNCT03833089Phase 41 country
- Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)CompletedNCT05118022Not applicable1 country
- Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrateCompletedNCT02665117Not applicable1 country
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT014313265 countries
- CXCR4 Targeted PET Imaging in APA Preoperative Localization DiagnosisStatus unknownNCT05839483Not applicable1 country
- Occurrence of Dyskalemia With Treatment for HypertensionCompletedNCT05155436Phase 41 country
- Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium LevelsCompletedNCT051849981 country
- Renal Tubular Disorders in Egyptian ChildrenCompletedNCT048458151 country
- Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and SodiumStatus unknownNCT02709031Phase 1/2
- Outcome of Patients With Primary AldosteronismStatus unknownNCT044288271 country
- The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of PhlebitisTerminatedNCT02082717Phase 41 country
- Hypomagnesemia Associated With Proton-Pump Inhibitor UseCompletedNCT044269941 country
- The Effect of a Diet Based on Low Sodium and Slowly Absorbed Carbohydrates on the Incidence of Refeeding Syndrome in Patients With Head and Neck CancerCompletedNCT01845922Not applicable1 country
- Intravenous Fluids in Hospitalised ChildrenCompletedNCT02926989Phase 41 country
- A Translational Approach to Gitelman SyndromeCompletedNCT00822107Not applicable1 country
- Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure UnitCompletedNCT034050511 country
- Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl CotransporterCompletedNCT02035046Not applicable1 country
- Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaClStatus unknownNCT02721095Phase 41 country
- Natural History of Apparent Mineralocorticoid Excess SyndromeCompletedNCT004749423 countries
- Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)CompletedNCT02297048Phase 41 country
- Comparison of Dexmedetomidine and Remifentanil Infusion During CABGCompletedNCT01572454Not applicable1 country
- Comparison of Enteral Versus Intravenous Potassium SupplementationStatus unknownNCT02015962Phase 41 country
- Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing DiureticsCompletedNCT01146197Phase 1/21 country
- Dopamine in Acute Decompensated Heart Failure IITerminatedNCT01060293Phase 42 countries
- Hypokalemia and Intravenous Patient Controlled AnalgesiaCompletedNCT01269099Not applicable1 country
- Safety of Continuous Potassium Chloride Infusion in Critical CareCompletedNCT00718068Phase 41 country
- Dopamine in Acute Decompensated Heart Failure (DAD-HF) TrialStatus unknownNCT00937092Phase 41 country
- Effect of Licorice and Hydrochlorothiazide on Plasma PotassiumCompletedNCT00605202Phase 41 country
- Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides DiureticsCompletedNCT00276289Not applicable1 country
- Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary HyperaldosteronismCompletedNCT00732771Phase 21 country